Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
about
A new strategy to fight antimicrobial resistance: the revival of old antibioticsMethicillin-resistant Staphylococcus aureus therapy: past, present, and futureA Cationic Amphiphilic Random Copolymer with pH-Responsive Activity against Methicillin-Resistant Staphylococcus aureusCotrimoxazole - optimal dosing in the critically ill.Cost-effectiveness and pricing of antibacterial drugs.Longevity and gender as the risk factors of methicillin-resistant Staphylococcus aureus infections in southern Poland.A current perspective on daptomycin for the clinical microbiologist.Current and prospective treatments for multidrug-resistant gram-positive infections.Use of daptomycin to treat infections with methicillin-resistant Staphylococcus aureus isolates having vancomycin minimum inhibitory concentrations of 1.5 to 2 μg/mL.Economic features of antibiotic resistance: the case of methicillin-resistant Staphylococcus aureus.Trimethoprim-sulfamethoxazole versus vancomycin for severe infections caused by meticillin resistant Staphylococcus aureus: randomised controlled trial.Nationwide surveillance of resistance rates of Staphylococcus aureus clinical isolates from Greek hospitals, 2012-2013.Evaluation of Vancomycin Use in Late-Onset Neonatal Sepsis Using the Area Under the Concentration-Time Curve to the Minimum Inhibitory Concentration ≥400 Target.8-Mercaptoguanine Derivatives as Inhibitors of Dihydropteroate Synthase.
P2860
Q21131083-2392FE5B-8A21-4CB6-B4CC-2F0121CD29EDQ27011165-330B633D-6670-4FEA-94D7-5921204EBCF3Q28468450-8EFE8832-DE5B-4812-862E-EA114D6333E0Q33652427-98B02963-12AE-4E0F-88F8-EE19535A44ABQ35084162-0D0590BA-59D1-4DCB-A904-AB52B2686014Q36277458-52C30DFD-952E-471D-A111-338022288C7CQ37263289-9EF6FB76-86FB-45B2-A6D5-CD27E728A20DQ38123255-74F7EB9F-BECC-45B5-97EB-9CCA829A4DE7Q38164663-D3279F60-51D8-4B9A-9452-94608207D2EEQ38275128-27BEC85A-DDF2-49B1-B37E-303F73E3D92EQ40155946-7400F712-DAF1-4594-BD30-D5C7DA253124Q40243934-0F9D1189-09A1-4229-BD49-C022DF9C82AFQ40327439-AA6F2E07-F25E-4FE9-B7F7-5361012B290CQ48241249-070A0AD0-BB5D-49D5-BA83-2059C5B1ED80
P2860
Treatment of methicillin-resistant Staphylococcus aureus infections with a minimal inhibitory concentration of 2 μg/mL to vancomycin: old (trimethoprim/sulfamethoxazole) versus new (daptomycin or linezolid) agents.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Treatment of methicillin-resis ...... ptomycin or linezolid) agents.
@en
type
label
Treatment of methicillin-resis ...... ptomycin or linezolid) agents.
@en
prefLabel
Treatment of methicillin-resis ...... ptomycin or linezolid) agents.
@en
P2093
P2860
P356
P1476
Treatment of methicillin-resis ...... ptomycin or linezolid) agents.
@en
P2093
Bharath Sunkara
Dror Marchaim
Emily T Martin
Harish Pulluru
Jason M Pogue
Judy Moshos
Kayoko Hayakawa
Keith S Kaye
Kimberley Ku
Melanie N Wilson
P2860
P304
P356
10.1345/APH.1R211
P407
P577
2012-12-04T00:00:00Z